Exhibitors & Sponsors
Over 4,000 physicians, surgeons, scientists, nurses, organ procurement personnel, pharmacists and other transplant professionals attend the American Transplant Congress each year. ATC is the foremost educational event in the field of basic and clinical transplantation. ATC enables you the unique opportunity to reach this audience over three and a half high-impact days. Attendees are looking for new information, education, products, and services to improve their field. Gain valuable exposure to the transplant community and ensure that they do business with you by contracting a booth today.
Get an Edge Over Your Competition
American Transplant Congress is the meeting to attend to gain visibility and a competitive edge in the transplantation market place. As a 2018 Exhibitor, you'll...
- Gain direct access to decision makers through face-to-face interaction. Research shows that face-to-face interaction is powerfully effective in educating your target audience and impacting their purchasing decisions.
- Showcase your line of products, technologies and recent innovations. ATC is a front-runner in delivering leading-edge products and technology to the transplantation community. It’s the ideal platform for spotlighting your best products and solutions.
- Elevate your company's brand. ATC provides a unique opportunity for your company or organization to gain prominence during one of the largest meetings for transplantation nationwide.
- Share your expertise and engage your audience directly. The exhibit hall’s interactive, educational environment is the perfect platform to educate, inform, and engage your buyers and put your offerings directly into their hands.
Beware of Unauthorized Attendee Contact List Sales - Data Analyst, World Data Providers, & StarTechLeads
ATC is the ONLY party that allows the purchase the 2018 pre-registration list. A company named ProSpace Media, Data Analyst, World Data Providers, and StarTechLeads are sending notifications that have the ability to sell the ATC registration list. This is false and you must beware that entering into financial agreements with non-endorsed companies can have costly consequences.